Temat: "Non-small-cell lung" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Comparison of early patient-reported outcomes between uniportal thoracoscopic segmentectomy and wedge resection for peripheral small-sized non-small-cell lung cancer.
Autorzy:: Zhao Y; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Liu W; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Gao X; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Zhang K; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Graduate School, Chengdu Medical college, Chengdu, 610041, Sichuan, China.
Dai W; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Wei X; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Zheng H; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Lei C; School of Public Health, Chongqing Medical University, Chongqing, 400016, China.
Yu H; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
Shi Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.; School of Public Health, Chongqing Medical University, Chongqing, 400016, China.; State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, 400016, China.
Li Q; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China.
Xie T; Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, 610041, Sichuan, China. .; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Apr 15; Vol. 19 (1), pp. 215. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Humans ; Aftercare ; Neoplasm Staging ; Patient Discharge ; Pneumonectomy/methods ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Autorzy:: Illini O; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Saalfeld FC; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases, 01307 Dresden, Germany.; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.
Christopoulos P; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Thoraxklinik and Translational Lung Research Center (TLRC), member of the German Center for Lung Research (DZL), Heidelberg University Hospital, 69126 Heidelberg, Germany.
Duruisseaux M; Respiratory Department and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, 69002 Lyon, France.; Oncopharmacology Laboratory, Cancer Research Center of Lyon, Unité Mixte de Recherche (UMR), Institut National de la Santé et de la Recherche Médicale (INSERM), 1052 Centre National de la Recherche Scientifique (CNRS), 5286 Lyon, France.; Université Claude Bernard, Université de Lyon, 69622 Villeurbanne cedex, France.
Vikström A; Department of Pulmonary Medicine, University Hospital Linköping, 58185 Linköping, Sweden.
Peled N; The Hemsely Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Demedts I; Department of Pulmonary Diseases, AZ Delta, Deltalaan 1, 8800 Roeselare, Belgium.
Dudnik E; Head, Thoracic Oncology Service, Assuta Medical Centers, Tel-Aviv 6329302, Israel.; Faculty of Health Sciences, Ben-Gurion Unversity of the Negev, Be'er Sheva 84105, Israel.
Eisert A; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50937 Cologne, Germany.
Hashemi SMS; Department of Pulmonary Medicine, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, 1081 Amsterdam, The Netherlands.
Janzic U; Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.; Medical Oncology Unit, University Clinic Golnik, 4204 Golnik, Slovenia.
Kian W; The Hemsely Cancer Center, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.; Institute of Oncology, Assuta Ashdod University Hospital, Ashdod 7747629, Israel.
Mohorcic K; Medical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
Mohammed S; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Kent TN24QJ, UK.
Silvoniemi M; Department of Pulmonary Diseases, Turku University Hospital, University of Turku, 20014 Turku, Finland.
Rothschild SI; Center for Oncology & Hematology and Comprehensive Cancer Center, Cantonal Hospital Baden, 5404 Baden, Switzerland.
Schulz C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Internal Medicine II, University Hospital, 93053 Regensburg, Germany.
Wesseler C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Pneumology, Asklepios Tumorzentrum Hamburg, Klinikum Harburg, 21075 Hamburg, Germany.
Addeo A; Oncology Department, University Hospital Geneva, 1205 Geneva, Switzerland.
Armster K; Department of Pneumology, Universitätsklinikum Krems, 3500 Krems an der Donau, Austria.
Itchins M; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.; Northern Clinical School, University of Sydney, St Leonards, NSW 2065, Australia.
Ivanović M; Department of Oncology, University Medical Centre Maribor, 2000 Maribor, Slovenia.
Kauffmann-Guerrero D; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Division of Respiratory Medicine and Thoracic Oncology, Department of Medicine V, Thoracic Oncology Center Munich, University Hospital, University of Munich (LMU), 81377 Munich, Germany.
Koivunen J; Department of Oncology and Radiotherapy, Oulu University Hospital, 90014 Oulu, Finland.; Cancer and Translational Medicine Research Unit, University of Oulu, 90014 Oulu, Finland.; Medical Research Center Oulu, 90014 Oulu, Finland.
Kuon J; Department Thoracic Oncology, SLK Fachklinik Löwenstein, 74245 Löwenstein, Germany.
Pavlakis N; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.; Northern Clinical School, University of Sydney, St Leonards, NSW 2065, Australia.
Piet B; Department of Respiratory Medicine, Radboudumc, 6225 GA Nijmegen, The Netherlands.
Sebastian M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Medicine, Hematology/Oncology, University Hospital, University of Frankfurt, 60596 Frankfurt am Main, Germany.
Velthaus-Rusik JL; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Wannesson L; Istituto Oncologico della Svizzera Italiana, 6500 Bellinzona, Switzerland.
Wiesweg M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; West German Cancer Center, Department of Medical Oncology, University Duisburg-Essen, 45147 Essen, Germany.
Wurm R; Division of Pulmonology, Department of Internal Medicine, LKH-Universitätsklinikum, Medical University of Graz, 8036 Graz, Austria.
Albers-Leischner C; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Aust DE; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Janning M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
Fabikan H; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Herold S; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Klimova A; Core Unit for Data Management and Analytics, National Center for Tumor Diseases, 01307 Dresden, Germany.
Loges S; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
Sharapova Y; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, 68167 Mannheim, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; German Center for Lung Research (DZL), 69120 Heidelberg, Germany.
Schütz M; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.
Weinlinger C; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Valipour A; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Overbeck TR; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen University, 37075 Göttingen, Germany.
Griesinger F; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Department of Hematology and Oncology, Pius University Hospital, University Medicine Oldenburg, 26121 Oldenburg, Germany.
Jakopovic M; Department for Respiratory Diseases Jordanovac, University Hospital Center Zagreb, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Hochmair MJ; Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna Healthcare Group, Bruenner Straße 68, A-1210 Vienna, Austria.; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, A-1210 Vienna, Austria.
Wermke M; Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.; National Center for Tumor Diseases, 01307 Dresden, Germany.; National Network Genomic Medicine Lung Cancer (nNGM), 50937 Cologne, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 03; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Aniline Compounds*
Indoles*
Pyrimidines*
Male ; Humans ; Female ; Aged ; ErbB Receptors/genetics ; Exons

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer.
Autorzy:: Luo WC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Mei SQ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Huang ZJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Chen ZH; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Zhang YC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Yang MY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Liu JQ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Xu JY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Yang XR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Zhong RW; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Tang LB; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Yin LX; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Deng Y; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Peng YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; School of Medicine, South China University of Technology, Guangzhou, China.
Lu C; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Chen BL; Xiamen Treatgut Biotechnology Co., Ltd, Xiamen, China.
Ke DX; Xiamen Treatgut Medical Laboratory Co., Ltd, Xiamen, China.
Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Xu CR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.; Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Apr 02; Vol. 22 (1), pp. 326. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/therapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/therapy
Lung Neoplasms*/drug therapy
Gastrointestinal Microbiome*
Humans ; Immunotherapy ; ErbB Receptors/genetics ; Anti-Bacterial Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Tenovin 3 induces apoptosis and ferroptosis in EGFR 19del non small cell lung cancer cells.
Autorzy:: Lv S; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Pan Q; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Lu W; The Fifth Affiliated Hospital of Jinan University (Heyuan Shenhe People's Hospital), Heyuan, 517000, China.
Zhang W; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Wang N; GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Huang L; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Li L; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Liu J; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Ma J; Medicine and Health Science College, Guangzhou Huashang College, Guangzhou, People's Republic of China.
Li Z; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Huang Y; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
Deng Q; GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macau Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China. .
Lei X; The Fifth Affiliated Hospital,Guangdong Province & NMPA & State Key Laboratory,School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7654. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Ferroptosis*
Humans ; ErbB Receptors/metabolism ; Apoptosis ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Protein Kinase Inhibitors/pharmacology ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
Autorzy:: Ohtaki Y; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
Nagashima T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
Okano N; Gunma University Heavy Ion Medical Center, Maebashi, Japan.
Kubo N; Gunma University Heavy Ion Medical Center, Maebashi, Japan.
Ohtaka T; Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Sunaga N; Division of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Japan.
Sakurai R; Division of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Japan.
Miura Y; Division of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Japan.
Nakazawa S; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
Kawatani N; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
Yazawa T; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
Yoshikawa R; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
Narusawa E; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.
Shirabe K; Department of General Surgical Science, Gunma University Graduate School of Medicine, Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital, Maebashi, Japan.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Apr; Vol. 15 (11), pp. 859-866. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Humans ; Retrospective Studies ; Protein-Tyrosine Kinases ; Neoplasm Recurrence, Local/pathology ; Proto-Oncogene Proteins ; Prognosis ; Lymph Nodes/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study.
Autorzy:: Wei Q; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Deng T; Pulmonary and Critical Care Medicine, Guang 'an People's Hospital, Guang 'an, China.
Wu J; Respiratory and Critical Care Medicine, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, China.
Zeng H; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Qi C; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tan S; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhang Y; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Huang Q; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Pu X; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xu W; Respiratory and Critical Care Medicine, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, China.
Li W; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Tian P; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .
Li Y; Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Respiratory Health and Multimorbidity, Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, Precision Medicine Center/Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 28; Vol. 24 (1), pp. 393. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/complications
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/complications
Lung Neoplasms*/drug therapy
Pleural Effusion, Malignant*/drug therapy
Pleural Effusion, Malignant*/pathology
Humans ; Male ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Immune Checkpoint Inhibitors/adverse effects ; Retrospective Studies ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer.
Autorzy:: Han F; Department of Medical Imaging, Tongji Hospital, School of Medicine, Tongji University, No. 389, Xincun Road, Putuo District, Shanghai, 200065, People's Republic of China.; Institute of Medical Imaging Artificial Intelligence, Tongji University School of Medicine, Shanghai, 200065, China.
Chen S; Department of Nuclear Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, People's Republic of China.
Zhang K; Department of Medical Imaging, Tongji Hospital, School of Medicine, Tongji University, No. 389, Xincun Road, Putuo District, Shanghai, 200065, People's Republic of China.; Institute of Medical Imaging Artificial Intelligence, Tongji University School of Medicine, Shanghai, 200065, China.
Zhang K; Department of Internal Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, People's Republic of China.
Wang M; Department of Radiotherapy, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, People's Republic of China.
Wang P; Department of Medical Imaging, Tongji Hospital, School of Medicine, Tongji University, No. 389, Xincun Road, Putuo District, Shanghai, 200065, People's Republic of China. .; Institute of Medical Imaging Artificial Intelligence, Tongji University School of Medicine, Shanghai, 200065, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 16; Vol. 22 (1), pp. 288. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/metabolism
Cancer-Associated Fibroblasts*/metabolism
Animals ; Mice ; Humans ; Proto-Oncogene Proteins c-akt/metabolism ; DNA Methylation/genetics ; Phosphatidylinositol 3-Kinases/genetics ; Phosphatidylinositol 3-Kinases/metabolism ; Radiation Tolerance/genetics ; Promoter Regions, Genetic/genetics ; Gene Expression Profiling ; Cell Line, Tumor ; Smad3 Protein/genetics ; Smad3 Protein/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC.
Autorzy:: de Miguel-Perez D; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Ak M; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Mamindla P; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Russo A; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Medical Oncology Unit, A.O. Papardo & Department of Human Pathology, University of Messina, Messina, Italy.
Zenkin S; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Ak N; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Peddagangireddy V; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Lara-Mejia L; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
Gunasekaran M; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.; Departments of Surgery and Pediatrics, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL, USA.
Cardona AF; Molecular Oncology and Biology Systems Research Group (Fox G), Universidad El Bosque, Bogota, Colombia.
Naing A; Departments of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hirsch FR; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
Colen RR; University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 15; Vol. 43 (1), pp. 81. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Letter
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Extracellular Vesicles*/pathology
Humans ; B7-H1 Antigen/therapeutic use ; Radiomics ; Multiomics ; Prospective Studies ; Biomarkers, Tumor ; Immunotherapy

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer.
Autorzy:: Sitthideatphaiboon P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand.
Nantavithya C; Division of Therapeutic Radiation and Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Chantranuwat P; Department of Pathology, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand.
Vinayanuwattikun C; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand.
Sriuranpong V; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, 1873 Henry Dunant Rd, Pathumwan, Bangkok, 10330, Thailand. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6146. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/metabolism
Humans ; Biomarkers ; Chemoradiotherapy ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Autorzy:: Kahraman S; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey. .
Karakaya S; Department of Medical Oncology, Ankara Ataturk Sanatoryum Training and Research Hospital, Ankara, Turkey.
Kaplan MA; Department of Medical Oncology, Dicle University Medical Faculty Hospital, Diyarbakir, Turkey.
Goksu SS; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Ozturk A; Department of Medical Oncology, Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Istanbul, Turkey.
Isleyen ZS; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Hamdard J; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Yildirim S; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Dogan T; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Isik S; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Celebi A; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Gulbagci BB; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Paksoy N; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Dogan M; Department of Medical Oncology, Ankara Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
Turk HM; Department of Medical Oncology, Faculty of Medicine Hospital, Bezmialem Vakif University, Istanbul, Turkey.
Bilici A; Department of Medical Oncology, Medipol University Hospital, Istanbul, Turkey.
Tatli AM; Department of Medical Oncology, Akdeniz University Hospital, Antalya, Turkey.
Akbas S; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Turan N; Department of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkey.
Hacibekiroglu I; Department of Medical Oncology, Sakarya University School of Medicine, Sakarya, Turkey.
Dogu GG; Department of Medical Oncology, Pamukkale University Medical Faculty Hospital, Denizli, Turkey.
Aydiner A; Department of Medical Oncology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sumbul AT; Department of Medical Oncology, Baskent University Adana Dr. Turgut Noyan Application and Research Center, Adana, Turkey.
Akyurek S; Department of Radiation Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Yalciner M; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Demirkazik A; Department of Medical Oncology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Gursoy P; Department of Medical Oncology, Ege University Medical Faculty Hospital, Izmir, Turkey.
Aykan MB; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Sahin E; Department of Medical Oncology, Kocaeli University Medical Faculty Hospital, Kocaeli, Turkey.
Karadag İ; Department of Medical Oncology, Hittite University Corum Training and Research Hospital, Corum, Turkey.
Kostek O; Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Er MM; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Artaç M; Department Of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey.
Duzkopru Y; Department of Medical Oncology, Ankara Etlik City Hospital, Ankara, Turkey.
Aydin D; Department of Medical Oncology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.
Isik D; Department of Medical Oncology, Kocaeli Medical Park Hospital, Kocaeli, Turkey.
Karakas Y; Department of Medical Oncology, Acıbadem Bodrum Hospital, Mugla, Turkey.
Kilickap S; Department of Medical Oncology, Liv Hospital, Istinye University, Ankara, Turkey.
Erol C; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Demir B; Department of Medical Oncology, Aydin Ataturk State Hospital, Aydin, Turkey.
Civelek B; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Turkey.
Ergun Y; Department of Medical Oncology, Batman Training and Research Hospital, Batman, Turkey.
Akinci MB; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.
Dogan I; Department of Medical Oncology, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
Karadurmus N; Department of Medical Oncology, Gulhane Training and Research Hospital, Ankara, Turkey.
Yumuk PF; Department of Medical Oncology, Koç University Medical Faculty Hospital, Istanbul, Turkey.
Sendur MAN; Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University, 06800, Ankara, Turkey.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5820. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Central Nervous System Neoplasms*/drug therapy
Humans ; Prognosis ; Retrospective Studies ; ErbB Receptors/genetics ; Treatment Outcome ; Protein Kinase Inhibitors/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study.
Autorzy:: Wu C; Department of Interventional Medicine,The Second Hospital of Shandong University, Institute of Tumor Intervention,Cheeloo college of medicine, Shandong University, Jinan City, Shandong Province, China.; Department of Fifth Internal Medicine, People's Hospital of Shizhong District, No.156 Jiefang Road, Zaozhuang City, Shandong Province, China.
Cao B; Department of Oncology, Qufu Hospital of Traditional Chinese Medicine, No.129 Canggeng Road, Qufu City, Shandong Province, China.
He G; Department of Interventional Medicine, Weifang Second People's Hospital, Weifang city, Shandong Province, China.
Li Y; Department of Interventional Medicine,The Second Hospital of Shandong University, Institute of Tumor Intervention,Cheeloo college of medicine, Shandong University, Jinan City, Shandong Province, China.
Wang W; Department of Interventional Medicine,The Second Hospital of Shandong University, Institute of Tumor Intervention,Cheeloo college of medicine, Shandong University, Jinan City, Shandong Province, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 06; Vol. 24 (1), pp. 304. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Humans ; Brachytherapy/adverse effects ; Microwaves/adverse effects ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Silencing PinX1 enhances radiosensitivity and antitumor-immunity of radiotherapy in non-small cell lung cancer.
Autorzy:: Qiu J; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Xia Y; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Bao Y; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Cheng J; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Liu L; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China.; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China.
Qian D; Division of Life Sciences and Medicine, Department of Radiation Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230001, China. .; Core Facility Center for Medical Sciences, The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei, 230001, Anhui, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 02; Vol. 22 (1), pp. 228. Date of Electronic Publication: 2024 Mar 02.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Telomerase*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Animals ; Mice ; Humans ; Tumor Suppressor Proteins/genetics ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; Radiation Tolerance ; Tumor Microenvironment ; RNA-Binding Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
Autorzy:: Gwon HR; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Pulmonology, National Cancer Center, Goyang, Korea.
La Woo A; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Yong SH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Park Y; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim SY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim EY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jung JY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kang YA; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Park MS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Park SY; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee SH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (9), pp. 730-737. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Humans ; Positron Emission Tomography Computed Tomography/methods ; Retrospective Studies ; Positron-Emission Tomography/methods ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.
Autorzy:: Wang Y; Department of Radiation Oncology, Shandong University Cancer Center, Jinan, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Gao Z; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Zhao W; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Li H; School of Pharmacy, Shandong University, Jinan, China.
Meng X; Department of Radiation Oncology, Shandong University Cancer Center, Jinan, China.; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Li J; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (8), pp. 642-653. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Lung Neoplasms*/genetics
Lung Neoplasms*/radiotherapy
Small Cell Lung Carcinoma*/pathology
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/pathology
Humans ; Retrospective Studies ; Treatment Outcome ; Neoplasm Staging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Efficacy and safety of 40 mg osimertinib administered every other day for non-small cell lung cancer harboring an epidermal growth factor receptor mutation: A single-center retrospective cohort study.
Autorzy:: Otsuki A; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Inoshima N; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Tochigi K; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Ito H; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Nakashima K; Department of Pulmonology, Kameda Medical Center, Kamogawa, Chiba, Japan.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 570-574. Date of Electronic Publication: 2024 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/chemically induced
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/chemically induced
Acrylamides*
Aniline Compounds*
Indoles*
Pyrimidines*
Humans ; Retrospective Studies ; Mutation ; ErbB Receptors/genetics ; Protein Kinase Inhibitors/adverse effects ; Weight Loss

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Autorzy:: Chiu LC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Hsu PC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Wang CC; Division of Pulmonary & Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Ko HW; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Kuo SC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Ju JS; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Tung PH; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Huang AC; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Yang CT; Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.; Department of Internal Medicine, Taoyuan Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Department of Respiratory Therapy, College of Medicine, Chang Gung University, Taoyuan, Taiwan.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2024 Mar; Vol. 15 (7), pp. 529-537. Date of Electronic Publication: 2024 Jan 26.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Liver Neoplasms*
Humans ; Afatinib/therapeutic use ; Progression-Free Survival ; Retrospective Studies ; ErbB Receptors/genetics ; Mutation ; Protein Kinase Inhibitors/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Quantification of preexisting lung ground glass opacities on CT for predicting checkpoint inhibitor pneumonitis in advanced non-small cell lung cancer patients.
Autorzy:: Wang X; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Department of Thoracic Oncology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China.
Zhao J; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Department of Radiology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China.
Mei T; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Department of Thoracic Oncology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China.
Liu W; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Department of Thoracic Oncology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China.
Chen X; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Department of Thoracic Oncology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China.
Wang J; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, China.; Department of Thoracic Oncology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China.
Jiang R; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China. .; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. .; Tianjin's Clinical Research Center for Cancer, Tianjin, China. .; Department of Thoracic Oncology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China. .
Ye Z; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China. .; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. .; Tianjin's Clinical Research Center for Cancer, Tianjin, China. .; Department of Radiology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China. .
Huang D; Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China. .; Key Laboratory of Cancer Prevention and Therapy, Tianjin, China. .; Tianjin's Clinical Research Center for Cancer, Tianjin, China. .; Department of Thoracic Oncology, Tianjin Cancer Institute & Hospital, Tianjin Medical University, Huanhuxi Road, Hexi District, 300060, Tianjin, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 26; Vol. 24 (1), pp. 269. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Pneumonia*/pathology
Humans ; Cohort Studies ; Lung/pathology ; Tomography, X-Ray Computed ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
Autorzy:: Zou M; Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Zhang B; Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Shi L; Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
Mao H; Department of Radiology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Huang Y; Department of Radiology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
Zhao Z; Department of Radiology, Shaoxing People's Hospital, Shaoxing, Zhejiang, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 23; Vol. 14 (1), pp. 4447. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Carcinoma, Squamous Cell*/diagnostic imaging
Carcinoma, Squamous Cell*/genetics
Humans ; Vascular Endothelial Growth Factor A/genetics ; Genes, erbB-1 ; Contrast Media ; Magnetic Resonance Imaging/methods ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Perfusion ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy.
Autorzy:: Chen K; Taizhou hospital of Zhejiang Province, Shaoxing University, Zhejiang Province, Taizhou, 317000, China.; Department of Radiation Oncology, Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, Taizhou, 317000, China.
Li S; Taizhou hospital of Zhejiang Province, Shaoxing University, Zhejiang Province, Taizhou, 317000, China.; Department of Radiation Oncology, Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, Taizhou, 317000, China.
Chen M; Department of Radiation Oncology, Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, Taizhou, 317000, China.
Jin Z; Department of Radiation Oncology, Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, Taizhou, 317000, China.
Sun X; Department of Radiation Oncology, Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, Taizhou, 317000, China.
Zhou S; Department of Radiation Oncology, Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, Taizhou, 317000, China. .
Yang H; Taizhou hospital of Zhejiang Province, Shaoxing University, Zhejiang Province, Taizhou, 317000, China. .; Department of Radiation Oncology, Key Laboratory of Radiation Oncology of Taizhou, Radiation Oncology Institute of Enze Medical Health Academy, Taizhou Hospital Affiliated to Wenzhou Medical University, Zhejiang Province, Taizhou, 317000, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Feb 23; Vol. 24 (1), pp. 257. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/drug therapy
Pneumonia*/chemically induced
Pneumonia*/epidemiology
Radiation Pneumonitis*/epidemiology
Radiation Pneumonitis*/etiology
Recombinant Proteins*
Endostatins*
Humans ; Retrospective Studies ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer.
Autorzy:: Mason M; Bristol Myers Squibb, Princeton, NJ, USA.
Lapuente-Santana Ó; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Halkola AS; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
Wang W; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
Mall R; Qatar Computing Research Institute, Hamad Bin Khalifa University, P.O. Box 34110, Doha, Qatar.; Department of Immunology, St. Jude Children's Research Hospital, P.O. Box 38105, Memphis, TN, USA.; Biotechnology Research Center, Technology Innovation Institute, P.O. Box 9639, Abu Dhabi, United Arab Emirates.
Xiao X; School of Informatics, Xiamen University, Xiamen, China.; National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China.
Kaufman J; Department of Medicine, Duke University, Durham, NC, USA.; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
Fu J; Dana-Farber Cancer Institute, Boston, MA, USA.
Pfeil J; AbbVie, South San Francisco, CA, USA.
Banerjee J; Sage Bionetworks, Seattle, WA, USA.
Chung V; Sage Bionetworks, Seattle, WA, USA.
Chang H; Bristol Myers Squibb, Princeton, NJ, USA.
Chasalow SD; Bristol Myers Squibb, Princeton, NJ, USA.
Lin HY; Bristol Myers Squibb, Princeton, NJ, USA.
Chai R; Sage Bionetworks, Seattle, WA, USA.
Yu T; Sage Bionetworks, Seattle, WA, USA.
Finotello F; Institute of Molecular Biology, University of Innsbruck, Innsbruck, Austria.; Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria.
Mirtti T; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.; iCAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Department of Biomedical Engineering, School of Medicine, Emory University, Atlanta, GA, USA.
Mäyränpää MI; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Bao J; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
Verschuren EW; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Ahmed EI; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar.
Ceccarelli M; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', 80125, Naples, Italy.; BIOGEM Institute of Molecular Biology and Genetics, Via Camporeale, Ariano Irpino, Italy.
Miller LD; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
Monaco G; BIOGEM Institute of Molecular Biology and Genetics, Via Camporeale, Ariano Irpino, Italy.
Hendrickx WRL; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 26999, Doha, Qatar.
Sherif S; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 26999, Doha, Qatar.
Yang L; Dana-Farber Cancer Institute, Boston, MA, USA.
Tang M; Dana-Farber Cancer Institute, Boston, MA, USA.
Gu SS; Dana-Farber Cancer Institute, Boston, MA, USA.
Zhang W; Dana-Farber Cancer Institute, Boston, MA, USA.
Zhang Y; Dana-Farber Cancer Institute, Boston, MA, USA.
Zeng Z; Dana-Farber Cancer Institute, Boston, MA, USA.
Das Sahu A; Dana-Farber Cancer Institute, Boston, MA, USA.
Liu Y; Dana-Farber Cancer Institute, Boston, MA, USA.
Yang W; Aginome Scientific, Xiamen, China.
Bedognetti D; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 26999, Doha, Qatar.; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Tang J; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Eduati F; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.; Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands.
Laajala TD; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.; iCAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; FICAN West Cancer Centre, University of Turku and Turku University Hospital, Turku, Finland.; Department of Pharmacology, Anschutz Medical Campus, University of Colorado, Denver, CO, USA.
Geese WJ; Bristol Myers Squibb, Princeton, NJ, USA.
Guinney J; Tempus Labs, Chicago, IL, USA.
Szustakowski JD; Bristol Myers Squibb, Princeton, NJ, USA.
Vincent BG; Department of Medicine, Division of Hematology, Department of Microbiology and Immunology, Curriculum in Bioinformatics and Computational Biology, Computational Medicine Program, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Carbone DP; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Feb 21; Vol. 22 (1), pp. 190. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/pathology
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; B7-H1 Antigen ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Non-small-cell lung"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji